Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > Rock and Roll

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on Dec 10, 2020 12:22pm

145 Views

Post# 32077289

RE:Rock and Roll

NAGGY23 wrote: VPH will be 1.50 to $1.75 by end of month ..

A lot depends on the Xmas selling. People may take profits to fund their Xmas. Also depends on VPH management releasing any additional NRs before Xmas. If they decide to wait until the New Year we will inevitably see the SP range bound between $ 1.15 to $ 1.30 IMO. The SP is news driven as you saw with the NR about Redesca.
JMHO.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing